133 Publications (Page 4 of 6)
Phase I Trial of High-Dose Clofarabine and Busulfan as a Myeloablative Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Leukemia
Farag, SherifFarag, SherifWood, Lisa LWood, Lisa LSchwartz, Jennifer ESchwartz, Jennifer ESrivastava, ShivaniSrivastava, ShivaniNelson, Robert PNelson, Robert PRobertson, MichaelRobertson, MichaelAbonour, RafatAbonour, RafatSayar, HamidSayar, HamidCripe, Larry D and Cripe, Larry D
Blood, vol. 114, (no. 22), pp. 198, 2009-11-20. | Journal Article
Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse
Levis, MarkRavandi, FarhadWang, Eunice SBaer, Maria RPerl, AlexanderCoutre, StevenErba, HarryStuart, Robert KBaccarani, MicheleCripe, Larry DTallman, Martin SMeloni, GiovannaGodley, Lucy ALangston, Amelia AAmadori, SergioLewis, Ian DNagler, ArnonStone, RichardYee, KarenAdvani, AnjaliDouer, DanJedrzejczak, Wieslaw WJuliusson, GunnarLitzow, Mark RPetersdorf, StephenSanz, MiguelKantarjian, Hagop MSato, TakashiTremmel, LotharBensen-Kennedy, Debra MSmall, Donald and Smith, B. Douglas
Blood, vol. 114, (no. 22), pp. 788, 2009-11-20. | Journal Article
T.133. Post-Engraftment Anti-CD25 for the Prevention of Acute Graft-versus-host disease (GVHD) after Minimally Intensive Cyclophosphamide/Fludarabine (Cy/Flu) Conditioning and Hematopoietic Cell Transplantation
Nelson, RobertNelson, RobertNelson, R.Robertson, MichaelRobertson, M.Robertson, MichaelSchwartz, J.Schwartz, JenniferSchwartz, JenniferCornetta, KennethCornetta, KennethCornetta, Kenneth GSrivastava, ShivaniSrivastava, ShivaniSrivastava, ShivaniKiel, PatrickKiel, PatrickKiel, P.Yu, MenggangYu, MenggangYu, MenggangWood, LisaWood, L.Wood, LisaBaute, JohnBaute, J.Baute, JohnO'Bryant, R.O'Bryant, RobinO'Bryant, RobinCripe, L.Cripe, LarryCripe, LarryAbonour, RafatAbonour, RafatAbonour, R.Farag, SherifFarag, S. and Farag, Sherif
Clinical Immunology, vol. 131, pp. S91, 2009. | Journal Article
The Discovered Story: The Evolution of Truth in Cancer Narratives
Cripe, Larry
Literature and Medicine, vol. 28, (no. 2), pp. vi-x, Fall 2009. | Journal Article
Transcriptional Repression of DAPK1 Characterizes a Resistant Phenotype of AML Enforced by Flt3 Signaling and Exclusive Nuclear Abundance of Non-Canonical NFkB2/p52: Synergistic Activity for Flt3 Inhibition along with HDAC Inhibition, or by NFkB Inhibition, for Potentiating ER Stress Apoptosis
Shanmugam, RajasubramaniamShanmugam, RajasubramaniamWilson-Weekes, AnniqueWilson-Weekes, AnniqueSayar, HamidSayar, HamidSuvannasankha, AttayaSuvannasankha, AttayaCardoso, Angelo ACardoso, Angelo ASargent, Katie JSargent, Katie JCripe, Larry DCripe, Larry DKalvakolanu, Dhananjaya VKalvakolanu, Dhananjaya VBoswell, H. Scott and Boswell, H. Scott
Blood, vol. 114, (no. 22), pp. 2387, 2009-11-20. | Journal Article
Fostamatinib Disodium (FosD), An Oral Inhibitor of Syk, Is Well-Tolerated and Has Significant Clinical Activity in Diffuse Large B Cell Lymphoma (DLBCL) and Chronic Lymphocytic Leukemia (SLL/CLL)
Friedberg, Jonathan WSharman, JeffSchaefer-Cutillo, JuliaJohnston, Patrick BDe Vos, SvenLaCasce, AnnLeonard, John PCripe, Larry DSinha, RajniGregory, Stephanie ASweetenham, JohnVose, Julie MLowe, Ann MLevy, R and Shipp, Margaret A
Blood, vol. 112, (no. 11), pp. 3, 2008-11-16. | Journal Article
Lenalidomide and Prednisone for Primary and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis (MF): An Eastern Cooperative Oncology Group (ECOG) Phase II Trial
Mesa, Ruben AYao, XiaopanCripe, Larry DLi, Chin YangTefferi, Ayalew and Tallman, Martin S
Blood, vol. 112, (no. 11), pp. 1753, 2008-11-16. | Journal Article
Music imagery for adults with acute leukemia in protective environments: a feasibility study.
Burns, Debra SAzzouz, FaouziSledge, RenataRutledge, CherylHincher, KatieMonahan, Patrick O and Cripe, Larry D
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, vol. 16, (no. 5), pp. 507-13, 2008/May. | Journal Article
Phase 2 Study of Voreloxin (Formerly Known as SNS-595) as Single Agent Therapy for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia (AML): Preliminary Safety and Clinical Responses (The REVEAL-1 Study)
Maris, MichaelCripe, Larry DStuart, Robert KRavandi, FarhadMichelson, Glenn CHawtin, Rachel EEricson, Lyra E and Berman, Craig J
Blood, vol. 112, (no. 11), pp. 1951, 2008-11-16. | Journal Article
Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes
Giagounidis, AristotelesFenaux, PierreMufti, GhulamMuus, PetraPlatzbecker, UweSanz, GuillermoCripe, LarryVon Lilienfeld-Toal, Marie and Wells, Richard
Annals of Hematology, vol. 87, (no. 5), pp. 345-52, May 2008. | Journal Article
Preliminary Results of a Phase 1/2, Multi-Center, Open-Label Study (CLL- 001) Investigating a Stepwise Dose-Escalation Schedule of Lenalidomide in Relapsed or Refractory Chronic Lymphocytic Leukemia
Wendtner, Clemens MMahadevan, DarukaStilgenbauer, StephanFrankfurt, OlgaBloor, AdrianBosch, FrancescUharek, LutzFurman, Richard RGobbi, MarcoGribben, John GKimby, Eva KSekeres, Mikkael ACripe, Larry DLombardy, ElyaneShah, SheetalParseval, Laure A Moutouh-deChanan-Khan, Asher Alban and Knight, Robert D
Blood, vol. 112, (no. 11), pp. 2104, 2008-11-16. | Journal Article
The end-of-life discussion: a second opinion on 'hope'
Cripe, Larry and Wong, Michael
HEM/ONC Today, vol. 9, (no. 16), pp. 5, 20080910. | Journal Article
Treating low-risk myelodysplastic syndromes in the community setting
Cripe, Larry D
Clinical advances in hematology & oncology : H&O, vol. 6, (no. 6), pp. 418, 2008-Jun. | Journal Article
Voreloxin (formerly known as SNS-595) in Combination with Cytarabine Demonstrates Preliminary Clinical Responses in a Phase 1 Study in Relapsed/Refractory Acute Myeloid Leukemia
Lancet, JeffreyKarp, Judith ECripe, Larry DRoboz, Gail JSuster, MattTan, NguyenHawtin, RachaelFox, JudithBerman, Craig and Michelson, Glenn
Blood, vol. 112, (no. 11), pp. 1955, 2008-11-16. | Journal Article
A 3,239 -Patient Combined Eastern Cooperative Oncology Group (ECOG), M.D. Anderson Cancer Center (MDA) Analysis of the Effect of CR vs. Responses < CR on Long-Term Survival in Newly-Diagnosed AML Treated with Ara-C-Containing Regimens: Implications for Targeted Drug Development
Estey, ElihuSun, ZhuoxinRowe, JacobFaderl, StefanCassileth, PeterSartiano, GeorgeTartaglia, AnthonyGarcia-Manero, GuillermoCripe, LarryBennett, JohnKantarjian, Hagop and Tallman, Martin
Blood, vol. 110, (no. 11), pp. 298, 2007-11-16. | Journal Article
A multicenter phase 2 study of the farnesyltransferase inhibitor tipifarnib in intermediate- to high-risk myelodysplastic syndrome.
Fenaux, PierreFenaux, PierreRaza, AzraRaza, AzraMufti, Ghulam JMufti, Ghulam JAul, CarloAul, CarloGerming, UlrichGerming, UlrichKantarjian, HagopKantarjian, HagopCripe, LarryCripe, LarryKerstens, RenéKerstens, RenéDe Porre, PeterDe Porre, PeterKurzrock, Razelle and Kurzrock, Razelle
Blood, vol. 109, (no. 10), pp. 4158-4163, May 15, 2007. | Journal Article
A Woman with Facial Papules and Pulmonary Nodules
Erickson, Bradley WErickson, Bradley WErickson, Bradley WCripe, LarryCripe, LarryCripe, LarryRieger, KarenRieger, KarenRieger, KarenCummings, Oscar WCummings, Oscar WCummings, Oscar WWilkes, DavidWilkes, David and Wilkes, David
Respiration, vol. 74, (no. 4), pp. 474, 20070700. | Journal Article
A Woman with Facial Papules and Pulmonary Nodules
Erickson, BradleyCripe, LarryRieger, KarenCummings, Oscar and Wilkes, David
(pp. 471-4). Jul 2007
Final Report of Toxicity and Efficacy of a Phase II Study of Oral Cyclophosphamide, Thalidomide, and Prednisone for Patients with Relapsed or Refractory Multiple Myeloma: A Hoosier Oncology Group Trial, HEM01-21
Suvannasankha, AttayaSuvannasankha, AttayaFausel, ChristopherFausel, ChristopherJuliar, BethJuliar, Beth EYiannoutsos, Constantin TYiannoutsos, ConstantinFisher, William BFisher, WilliamAnsari, RafatAnsari, Rafat HWood, Lisa LWood, LisaSmith, Gina GSmith, GinaCripe, Larry DCripe, LarryAbonour, Rafat and Abonour, Rafat
The Oncologist, vol. 12, (no. 1), pp. 106, 20070101. | Journal Article
Mechanistic Paradigm for Combination Signal Transduction Inhibitor Therapy in Zap70+ CLL Involves Bicompartmental Functions of EZH2
Hartman, Amy DWilson-Weekes, AnniqueRuffin, TheresaHincher, Katie JCripe, Larry D and Boswell, H. Scott
Blood, vol. 110, (no. 11), pp. 3099, 2007-11-16. | Journal Article
Phase I/II Study of the P-Glycoprotein (Pgp) Inhibitor Zosuquidar Administered by Continuous Infusion (CIV) with Daunorubicin (DNR) and Cytarabine (ARA-C) as Primary Therapy in Older Patients with Pgp-Positive Acute Myeloid Leukemia (AML)
Lancet, Jeffrey EGotlib, JasonWetzler, MeirLuger, SelinaCripe, Larry DTallman, Martin SGojo, IvanaMulford, DeborahBaer, Maria RList, Alan FMultani, Pratik S and Sikic, Branimir I
Blood, vol. 110, (no. 11), pp. 299, 2007-11-16. | Journal Article
A piece of my mind. Hope is the thing with feathers.
Cripe, Larry D
JAMA : the journal of the American Medical Association, vol. 296, (no. 15), pp. 1815-6, 2006/Oct/18. | Journal Article
A Randomized, Placebo-Controlled, Double Blind Trial of the MDR Modulator, Zosuquidar, during Conventional Induction and Post-Remission Therapy for Pts > 60 Years of Age with Newly Diagnosed Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (HR-MDS): ECOG 3999
Cripe, Larry DLi, XiaochunLitzow, MarkPaietta, ElisabethRowe, Jacob MLuger, Selina and Tallman, Martin
Blood, vol. 108, (no. 11), pp. 423, 2006-11-16. | Journal Article
Constitutive c-jun N-terminal kinase activity in acute myeloid leukemia derives from Flt3 and affects survival and proliferation.
Hartman, Amy DWilson-Weekes, AnniqueSuvannasankha, AttayaBurgess, Gem SPhillips, Carissa AHincher, Katie JCripe, Larry D and Boswell, H Scott
Experimental hematology, vol. 34, (no. 10), pp. 1360-1376, October 2006. | Journal Article
Desensitization to imatinib in patients with leukemia
Nelson, Robert PNelson, Robert PCornetta, Kenneth GCornetta, KennethWard, Kelly EWard, Kelly ERamanuja, SrinivasanRamanuja, SrinivasanFausel, ChrisFausel, ChrisCripe, Larry D and Cripe, Larry D
Annals of Allergy, Asthma & Immunology, vol. 97, (no. 2), pp. 222, 2006. | Journal Article